Autopsy report · NCT03172988

Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Protocol violation occurred frequently during the postoperative period.”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 1 year 5 months before it stopped.
126 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 4
Sponsor: Peking University First Hospital
Sponsor type: University, hospital or other
Conditions: Carcinoma, Non-Small-Cell Lung; Surgery; Dexamethasone; Flubiprofen Axetil; Long-term Effects Secondary to Cancer Therapy in Adults
Interventions: Dexamethasone; Normal saline; Flurbiprofen axetil; Lipid microsphere
Participants: 126
Sites: 2
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.